However, given that the intensity of SLFN11 expression was highly heterogeneous in some tumor tissues before CRT (Supplementary Figure 5), it is possible that a population of cells with low SLFN11 expression in the primary tumors may have survived and proliferated after CRT. This evidence concerns the gene SLFN11 and neoplasm.